RHAMM/HMMR (CD168) is not an ideal target antigen for immunotherapy of acute myeloid leukemia (Q36366953)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | RHAMM/HMMR (CD168) is not an ideal target antigen for immunotherapy of acute myeloid leukemia |
scientific article |
Statements
1 reference
RHAMM/HMMR (CD168) is not an ideal target antigen for immunotherapy of acute myeloid leukemia (English)
1 reference
Tom Taghon
1 reference
Sylvia Snauwaert
1 reference
Glenn Goetgeluk
1 reference
Greet Verstichel
1 reference
Yasmine Van Caeneghem
1 reference
Imke Velghe
1 reference
Jan Philippé
1 reference
Jean Plum
1 reference
Kris Thielemans
1 reference
Tessa Kerre
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference